Australia’s approach to musculoskeletal injury care and reimbursement demands rethink: Report Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announces a new report examining musculoskeletal injury care and reimbursement in Australia that urges health payers and...

New study confirms Smith+Nephew’s REGENETEN™ Bioinductive Implant reduces full-thickness rotator cuff re-tear rates¹ by 68% First published randomized controlled trial for market-leading implant demonstrates impressive outcomes for rotator cuff tears                Smith+Nephew (LSE:SN, NYSE:SNN), the...